Main Menu
Menu

Frank Cullen

Publish Date
Op-Eds
‘The stakes can’t be overstated’: IP theft in the US
WIPR
News
USPTO Updates Eligibility Guidance for AI: ‘We Want to Accelerate AI Innovation Without Locking it Up’
IPWatchdog
Op-Eds
Letters from readers on schools and bird flu, opioid ‘overprescribing,’ and more
STAT
BlogOp-Eds
New Patent Guidance on AI Could Quash Innovation

C4IP Co-Chairs and former USPTO Directors Andrei Iancu and David Kappos just published a new opinion piece in the Wall Street Journal...

The Wall Street Journal
Blog
Inventor Spotlight: Jaap Haartsen

C4IP is celebrating Jaap Haartsen, whose invention of Bluetooth wireless technology has helped integrate electronic devices seamlessly into our daily lives. Haartsen...

News
Drug Pricing, Overreach Dominate IP Disclaimer Feedback
Law360
News
FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority
IPWatchdog
Resources
Public Comments
C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003)
Blog
C4IP Coalition Updates: June 2024

June was a productive month for C4IP! Here’s a roundup of what our Coalition accomplished over the past month. June Highlights: Combating...

Blog
This Month in IP: June 2024

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From office...

BlogFact Checks
Fact Check: Patents Are Not To Blame for High Drug Prices

Like inventors in every sector, drug developers rely on strong patent protections to create new and innovative medicines. However, because of the...

News
USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section
Law360
Op-Eds:

Op-Eds:

‘The stakes can’t be overstated’: IP theft in the US,

07/16/2024
News:

News:

USPTO Updates Eligibility Guidance for AI: ‘We Want to Accelerate AI Innovation Without Locking it Up’,

07/16/2024
Op-Eds:

Op-Eds:

Letters from readers on schools and bird flu, opioid ‘overprescribing,’ and more,

07/13/2024
Op-Eds:

Blog, Op-Eds:

New Patent Guidance on AI Could Quash Innovation,

07/11/2024
Blog:

Blog:

Inventor Spotlight: Jaap Haartsen,

07/10/2024
News:

News:

Drug Pricing, Overreach Dominate IP Disclaimer Feedback,

07/10/2024
News:

News:

FTC Backs USPTO Terminal Disclaimer NPRM as Others Warn it Exceeds Agency Authority,

07/10/2024
Resources:

Resources:

C4IP Comments RE: Terminal Disclaimer Practice to Obviate Nonstatutory Double Patenting (PTO-P-2024-0003),

07/09/2024
Blog:

Blog:

C4IP Coalition Updates: June 2024,

07/02/2024
Blog:

Blog:

This Month in IP: June 2024,

07/02/2024
Blog:

Blog, Fact Checks:

Fact Check: Patents Are Not To Blame for High Drug Prices,

06/26/2024
News:

News:

USPTO’s AI-Assisted Inventions Guidance Irks ABA IP Section,

06/20/2024
Scroll to Top